GlobeNewswire

Experts call for greater understanding of ‘bedwetting’ as a medical condition

Share
  • Bedwetting, also known as enuresis, is an uncontrollable leakage of urine while asleep1
     
  • Bedwetting is common in children, with approximately 5–10% of 7-year-olds regularly wetting their beds and the problem may persist into teenage and adulthood2
     
  • In most cases, bedwetting is a complex medical condition caused by over-production of urine at night or reduced capacity of the bladder, which can impact a child’s overall self-esteem, emotional well-being and day time functioning1 , 3

SAINT-PREX, Switzerland, May 27, 2019 (GLOBE NEWSWIRE) -- Recent survey findings highlighted there are misconceptions underlying bedwetting, a condition that is under-recognised and misunderstood by society and healthcare professionals.3,4 A frequent misconception of bedwetting is that the cause is psychological, rather than having a multifactorial pathophysiological basis.1 , 4 Furthermore, the survey revealed that not only parents but also health care providers share this misconception and treatment was not necessarily consistent with guidelines.4

“For physicians to effectively treat bedwetting, any existing behavioural issues must be managed as a separate condition,” said Dr. Michal Maternik, Department of Urology, Division of Paediatric Urology, Medical University of Gdansk, Poland. “The survey findings highlight the need for new educational initiatives to optimise the understanding of bedwetting and provision of care amongst the medical community, parents and the public.”

Bedwetting can lead to feelings of shame and low self-esteem, preventing many patients from seeking treatment.3 , 4 According to the new survey, patients and their respected caregivers reported bedwetting to be associated with behavioural difficulties including, ‘sustaining attention’ (28%), ‘maintaining attention at school’ (29%), and sleeping difficulties (21%) resulting in repercussions on school performance.4 These consequences are often prolonged as many parents seek lifestyle changes first and nearly half of them do not seek help in children five years or older.4

“For decades, bedwetting was considered as a simple condition that would resolve spontaneously,” said Professor Serdar Tekgül at the Department of Urology at Hacettepe University, Turkey. “Bedwetting is now regarded as a complex disorder involving several factors such as bladder dysfunction, and the over-production of urine at night”.

The survey was completed by physicians and patients in Alpe-Adria, Italy, Romania, Russia, Serbia and Slovakia on their understanding of the medical condition, its impact on the lives of patients and the prevalence of comorbidities.4

About Bedwetting
Bedwetting, also known as enuresis, is an uncontrollable leakage of urine while asleep in children from aged 5 years.1 In most cases it is caused by over-production of urine at night or reduced capacity of the bladder.2 An inability to wake up can be another cause.2 Bedwetting does not have a psychological cause.1 Bedwetting is a common childhood medical condition, with approximately 5–10% of 7 year-olds regularly wetting their beds and the problem may persist into teenage and adulthood.2

About World Bedwetting Day
World Bedwetting Day was initiated to raise awareness among the public and healthcare professionals that bedwetting is a common medical condition that can and should be treated. World Bedwetting Day 2019 will take place on 28th May 2019 and occurs on the last Tuesday of May each year. The theme is: ‘Time to Take Action’, in recognition that much more can be done to diagnose and treat those children who suffer from bedwetting.

For more information please visit www.worldbedwettingday.com.

About the World Bedwetting Day Steering Committee
The World Bedwetting Day Steering Committee brings together experts from across the globe to support this initiative and consists of the International Children’s Continence Society (ICCS), the European Society of Paediatric Urology (ESPU), the Asia Pacific Association of Paediatric Urology (APAPU), the International Paediatric Nephrology Association (IPNA), the European Society of Paediatric Nephrology (ESPN), the Sociedad Iberoamericana de Urologia Paediatrica (SIUP), the North American Paediatric Urology Societies, ERIC (The Children's Bowel & Bladder Charity) and Bladder & Bowel UK. The initiative is supported by Ferring Pharmaceuticals. 

1 Theunis M et al. Self-Image and Performance in Children with Nocturnal Enuresis. European Urology. 2002; 41:660-667
2 Nevéus T. Nocturnal enuresis—theoretic background and practical guidelines. Pediatr Nephrol. 2011; 26:1207–1214
3 Vande Walle J et al, Practical consensus guidelines for the management of enuresis. Eur J Pediatr 2012;171:971-983
4 Maternik. Understanding of and misconceptions around monosymptomatic nocturnal enuresis: findings from patient and physician surveys. Journal of Pediatric Urology 2018

Contact:
Emma Barrow
Emma.barrow@gcihealth.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8147ae15-92f1-41ed-a13a-b1db5f6df6ec

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

CONDITIONS FOR RIKSBANK BID PROCEDURE KOMMUNINVEST BONDS14.8.2020 16:20:00 CESTPress release

Sveriges Riksbank Bid procedure details Kommuninvest Bonds, 2020-08-18 Maturity dateLoanISIN codeCouponVolume, SEK million2022-06-012206SE00092694180.25 %500 +/- 2502023-11-132311SE00109482401.00 %500+/- 2502025-05-12 2505 SE0011414010 1.00 % 500+/- 250 2026-11-12 2611 SE0012569572 1.00 % 500+/- 250 Maximum volume 2 000 million in total Settlement date 2020-08-20 Bids have to be entered by 11.00 on AUG 18, 2020 Highest permitted bid volume: 500 SEK million in issue 2206, 2311, 2505, and 2611. Lowest permitted bid volume: 50 SEK million Bids only through counterparties approved by the Riksbank RESULT OF AUCTION WILL BE PUBLISHED NO LATER THAN 11.15 (CEST) ON AUG 18, 2020 For more information, please contact: Trading desk at the Riksbank + 46 8 696 6970 General and special terms and conditions can be retrieved at http://www.riksbank.se

CONDITIONS FOR RIKSBANK BID PROCEDURES SEK GOVERNMENT BONDS14.8.2020 16:20:00 CESTPress release

Sveriges Riksbank Bid procedure details Government Bonds, 2020-08-21 Maturity dateLoanISIN codeCouponVolume, SEK million2028-05-121060SE00094963670.75 %1000 +/- 2502031-05-121062 SE00139353190.125 1000 +/- 250 Settlement date 2020-08-25 Bids have to be entered by 10.00 on AUG 21, 2020 Highest permitted bid volume: 1000 SEK million in issue SGB 1060 and 1000 SEK million in issue SGB 1062 Lowest permitted bid volume: 50 SEK million Bids only through counterparties approved by the Riksbank RESULT OF AUCTION WILL BE PUBLISHED NO LATER THAN 10.10 (CEST)ON AUG 21, 2020. For more information, please contact: Trading desk at the Riksbank + 46 8 696 6970 General and special terms and conditions can be retrieved at http://www.riksbank.se

SEK CREDIT OPERATION ANNOUNCEMENT14.8.2020 16:20:00 CESTPress release

SEK CREDIT OPERATION ANNOUNCEMENT 2020-08-18 Transaction type:SEK CreditTender date:2020-08-18Time for submission of bids:11.00-11.30 (CEST)Payment date:2020-08-18 (at 3 pm)Maturity date:2020-11-16Duration:13 weeks. For credit in consequence of the auction on 18 August 2020, the maturity is however 12 weeks and 6 daysOffered volume:UnlimitedLowest accepted bid volumeSEK 50 millionMaximum number of bids from each participant: 1RateRepo rate Transaction type:SEK CreditTender date:2020-08-18Time for submission of bids:11.00-11.30 (CEST)Payment date:2020-08-18 (at 3 pm)Maturity date:2021-02-15Duration:26 weeks. For credit in consequence of the auction on 18 August 2020, the maturity is however 25 weeks and 6 days. Offered volume:UnlimitedLowest accepted bid volumeSEK 50 millionMaximum number of bids from each participant: 1RateRepo rate All monetary counterparties are invited to submit volume bids to the Riksbank, tel + 46 8 6966970 by 11.30 am on August 18, 2020. Confirmation of bids to e

CONDITIONS FOR RIKSBANK BID PROCEDURES SEK COVERED BONDS14.8.2020 16:20:00 CESTPress release

Sveriges Riksbank Bid procedure details Covered Bonds, 2020-08-20 Maturity dateLoanISIN codeCouponVolume, SEK million2025-09-175535 SE00133584131.00 %1,000 +/- 5002024-12-18579 SE00121936211.00 %1,000 +/- 500 2024-12-031589SE00116433861.50 %1,000 +/- 5002025-06-18195SE00135460661.00 %1,000 +/- 5002024-12-182412SE00126218521.00 %400 +/- 2502025-09-17518SE00113092441.25 %400 +/- 2502025-06-11146SE00133815711.00 %400 +/- 250 Settlement date 2020-08-24 Bids have to be entered by 10.00 on AUG 20 2020 Highest permitted bid volume: 1,000 SEK million in issue 5535 1,000 SEK million in issue 579 1,000 SEK million in issue 1589 1,000 SEK million in issue 195 400 SEK million in issue 2412 400 SEK million in issue 518 400 SEK million in issue 146 Maximum volume 5 billion SEK in total Lowest permitted bid volume: 50 SEK million Bids only through counterparties approved by the Riksbank RESULT OF AUCTION WILL BE PUBLISHED NO LATER THAN 10.15 (CEST) ON AUG 20, 2020. For more information, please conta

NEXSTIM ABP:S HALVÅRSRAPPORT 1/1–30/6 2020 (OREVIDERAD)14.8.2020 14:00:00 CESTPressemelding

Företagsmeddelande, Insiderinformation, Helsingfors 14 augusti 2020 kl. 15.00 (EEST) NEXSTIM ABP:S HALVÅRSRAPPORT 1/1–30/6 2020 (OREVIDERAD) Viktiga händelser januari–juni 2020 Vi fokuserade på att minimera effekterna av covid-19-pandemin och utforma en ny strategi. Med tanke på den svåra affärsmiljön gjorde vi goda framsteg genom att sälja fyra nya NBS-system, tre i USA och ett i EU och installera fem nya NBT®-system på kliniker i USA och Europa för behandling av egentlig depression. Halvåret 1/1–30/6 2020 var det bästa någonsin för bolaget, med avseende på omsättningen, rörelseresultatet och räkenskapsperiodens resultat. Bolagets totala omsättning under första halvåret var 1,6 miljoner euro (H1 2019: 1,2 mn euro), rörelseresultatet var -1,8 miljoner euro (H1 2019: -3,4 mn euro) och räkenskapsperiodens resultat var -1,2 miljoner euro (H1 2019: -3,7 mn euro). Under första halvåret ökade omsättningen för NBS (med 47 %) till 0,9 miljoner euro (H1 2019: 0,2 mn euro) och för NBT (med 18 %)

NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY – 30 JUNE 2020 (UNAUDITED)14.8.2020 14:00:00 CESTPress release

Company announcement, Inside Information, Helsinki, 14 August 2020 at 15:00 (EEST) NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY – 30 JUNE 2020 (UNAUDITED Highlights, January – June 2020 Focused on minimizing the effect of COVID-19 pandemic as well as updating company strategy. Considering the difficult business environment, good progress with four new NBS systems sold, three in the US one in the EU and a total of five new NBT® systems installed to clinics in the US and Europe, across multiple sites, for the treatment of Major Depressive Disorder (MDD) January 1 – June 30, 2020 was historically the Company’s best first half to date when measured by net sales, operating result and result for the period. The total net sales in the first half was EUR 1.6 million (2019 H1: EUR 1.2 million), operating result EUR -1.8 million (2019 H1: -3.4 million) and result for the period EUR -1.2 million (2019 H1: EUR -3.7 million) NBS net sales grew by 47% in H1 to EUR 0.9 million (2019 H1: EUR 0.6 million)